You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Details for New Drug Application (NDA): 040167

✉ Email this page to a colleague

« Back to Dashboard

NDA 040167 describes DOXYLAMINE SUCCINATE, which is a drug marketed by Copley Pharm, LNK, Perrigo, Quantum Pharmics, Actavis Labs Fl Inc, Bionpharma, Mylan Pharms Inc, and Ph Health, and is included in nine NDAs. It is available from thirty-two suppliers. Additional details are available on the DOXYLAMINE SUCCINATE profile page.

The generic ingredient in DOXYLAMINE SUCCINATE is doxylamine succinate; pyridoxine hydrochloride. There are fourteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the doxylamine succinate; pyridoxine hydrochloride profile page.

Summary for 040167

Tradename:	DOXYLAMINE SUCCINATE
Applicant:	Perrigo
Ingredient:	doxylamine succinate
Patents:	0

Pharmacology for NDA: 040167

Mechanism of Action	Histamine Receptor Antagonists

Medical Subject Heading (MeSH) Categories for 040167

Antiemetics
Histamine H1 Antagonists

Suppliers and Packaging for NDA: 040167

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
DOXYLAMINE SUCCINATE	doxylamine succinate	TABLET;ORAL	040167	ANDA	L. Perrigo Company	0113-0441	0113-0441-01	1 BOTTLE in 1 CARTON (0113-0441-01) / 96 TABLET in 1 BOTTLE
DOXYLAMINE SUCCINATE	doxylamine succinate	TABLET;ORAL	040167	ANDA	L. Perrigo Company	0113-0441	0113-0441-64	32 BLISTER PACK in 1 CARTON (0113-0441-64) / 1 TABLET in 1 BLISTER PACK

Profile for product number 001

Active Rx/OTC/Discontinued:	OTC	Dosage:	TABLET;ORAL			Strength	25MG
Approval Date:	Sep 18, 1996	TE:		RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.